Changes in Cognition and Psychiatric Disorder Symptoms During Cannabis Abstinence Using a Novel Discordant Twin Design
Enrolling by invitation · Not applicable
Conditions studied: Cannabis
In brief
This study will test whether 42 days of cannabis abstinence, compared to continued cannabis use, is associated with improvements in cognition and psychiatric disorder symptoms. Identical twins, who are concordant on cannabis use, will be experimentally-manipulated to be discordant for 42 days. Each twin, within a twin pair, will be randomly assigned to either the contingency management condition, incentive-based protocol to promote cannabis abstinence, or control condition, no changes in cannabis use requested.
Key facts
- Study ID
- NCT05160688
- Run by
- University of Colorado, Denver
- People needed
- 100
- Starts
- 2023-05-05
- Expected to finish
- 2026-04-01
- Last updated by the study team
- 2026-02-12
Who can join
Age: 31 and older, up to 47. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Monozygotic (MZ) twin pair, in which both twins are willing to participate
- MZ twin pair must be concordant in their frequency of cannabis use (+/- 2 days)
- Cannabis use at least 1x per week on most weeks
- Cannabis use in the past 7 days at the baseline visit
- Positive qualitative urine toxicology at baseline for THC
- Located within the state of Colorado
You may not qualify if…
- Discordance in the twin pairs on a significant, adverse experience, like traumatic brain injury.
Where it is running
- Jessica M Ross — Aurora, Colorado, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.